DREZ lesioning, midline myelotomy and chemical neurolytic agents
Procedural · G4e · Reviewed by a board-certified pain physician on November 2, 2026
Bottom line
DREZ lesioning treats deafferentation pain after root avulsion, punctate midline myelotomy targets refractory visceral pelvic and abdominal cancer pain, and alcohol and phenol differ in injection sensation, spread and intrathecal positioning.
Key points
- DREZ targets the dorsal horn generator. After avulsion, hyperexcitable dorsal horn neurons generate pain; lesioning disrupts the central dorsal rootlets, medial Lissauer tract and dorsal horn neurons 1.
- Avulsion pain responds durably. In 52 patients followed at least 10 years, mean pain fell from 8.6 to 2.4; 71.2% had complete relief initially and 53.8% at final follow-up 1.
- Midline myelotomy interrupts a visceral pathway. A midline dorsal column pathway may matter more than the spinothalamic tract for visceral nociception; punctate myelotomy has relieved intractable abdominal and pelvic cancer pain 2.
- Myelotomy relieved pain without deficits. In six patients with refractory visceral cancer pain, pain ratings and daily opioid use fell significantly without adverse neurological effects 3.
- Alcohol burns and spreads. Ethyl alcohol (at least 35–60%) causes burning on injection and spreads rapidly, so larger volumes are often needed; intrathecally the patient is tilted forward 45 degrees 4.
- Phenol is gentler and stays local. Phenol has local anesthetic properties and a warming sensation, spreads little in glycerin, and is injected intrathecally with the patient tilted backward 45 degrees 4.
Watch for
Chemical neurolysis is nonselective: off-target tissue damage, skin sloughing, post-procedure neuritis and, near the celiac plexus, vascular injury make it a therapy of last resort 4.
High-yield for the exam
- DREZ complications in the 10-year series were mainly mild proprioceptive disturbance (9 of 52), with motor weakness in one patient 1.
- Brachial plexus avulsion combined with cervical spinal cord injury correlated with poorer DREZ outcomes 1.
- DREZ lesions in the series were about 3–4 mm deep, angled roughly 35 degrees, targeting hyperactive dorsal horn neurons 1.
- Myelotomy was proposed when opioids cannot control cancer pain or their side effects are intolerable 3.
- Phenol concentrations for neurolysis are thought to range from 3% to 12%; it acts immediately and can be repeated within days 4.
- Alcohol neurolysis is routinely used for visceral cancer pain or for pain recurring after radiofrequency ablation 4.
- Phenol must be prepared by the hospital pharmacy, and it is unstable at room temperature and oxidizes in air and light 4.
Numbers to know
| Item | Value |
|---|---|
| DREZ pain score before and after | 8.6 to 2.4 1 |
| Complete relief at final follow-up | 53.8% 1 |
| Alcohol concentration for neurolysis | At least 35–60% 4 |
| Phenol concentration for neurolysis | 3–12% 4 |
| Intrathecal tilt, alcohol vs phenol | Forward vs backward 45 degrees 4 |
| Patients in the myelotomy series | 6 3 |
| DREZ lesion depth | About 3–4 mm 1 |
Common traps
Practise this topic
3 more questions on this topic in the full question bank, with explanations and sources.
Sources
- Jin W, et al. Long-term outcomes of dorsal root entry zone lesioning for neuropathic pain following brachial plexus avulsion: a 10-year follow-up study. Neurosurgery, 2026. pmc.ncbi.nlm.nih.gov/articles/PMC13148505/
- Hong D, et al. Punctate midline myelotomy: a minimally invasive procedure for the treatment of pain in inextirpable abdominal and pelvic cancer. J Pain Symptom Manage, 2007. pubmed.ncbi.nlm.nih.gov/17196911/
- Nauta HJ, et al. Punctate midline myelotomy for the relief of visceral cancer pain. J Neurosurg, 2000. pubmed.ncbi.nlm.nih.gov/10763680/
- Gupta M, et al. A Review of Nonsurgical Neurolytic Procedures for Neuropathic Pain. J Pain Res, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC11871951/
Related topics
Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.